May 18, 2026 08:57AM
Mar 31, 2026 09:13AM
Feb 11, 2026 08:02AM
Dec 23, 2025 04:31PM
Dec 4, 2025 08:37AM
Dec 1, 2025 12:08PM
Oct 20, 2025 08:38AM Citius Oncology signs distribution deal with McKesson for LYMPHIR launch
Oct 16, 2025 08:47AM
Aug 22, 2025 08:47AM
Jul 15, 2025 08:32AM
Jul 8, 2025 08:34AM
Jun 17, 2025 08:10AM
Jun 10, 2025 07:01AM
Jun 9, 2025 08:57AM Citius Oncology (CTOR) stock soars on distribution deal
Jun 9, 2025 08:38AM
May 14, 2025 06:16PM
Apr 14, 2025 06:44AM
Apr 1, 2025 09:01AM
Feb 6, 2025 08:57AM
Jan 8, 2025 08:00AM
Jan 7, 2025 08:08AM Citius Pharmaceuticals (CTXR) and Citius Oncology (CTOR) Highlight LYMPHIR Commercial Launch Planned for H1 of 2025
Dec 30, 2024 07:02AM
Nov 25, 2024 08:04AM
Nov 22, 2024 09:00AM
Nov 15, 2024 01:30PM
Nov 11, 2024 08:45AM
Aug 13, 2024 07:01AM
Aug 8, 2024 07:00AM Citius Pharmaceuticals (CTXR) Receives FDA Approval for LYMPHIR (denileukin diftitox-cxdl) Immunotherapy for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
Aug 5, 2024 08:02AM
Jul 18, 2024 07:00AM
Jul 17, 2024 08:00AM
Jul 15, 2024 09:35AM
Jul 11, 2024 11:00AM
Jul 11, 2024 08:00AM
Jul 10, 2024 09:10AM Citius Pharmaceuticals (CTXR) Details Near-Term Milestones for Late-Stage Candidates

405,028 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All